• Group
    • Companies
    • History
    • Business model
    • Mission and vision
    • Corporate values
    • Commitment to sport
  • Research
    • Pharmaceutical Research
    • Sucrosomial Technology
    • Cetylated Fatty Acids
    • Quality and certifications
  • Brands
    • PharmaNutra
      • SiderAL
      • SiderAL Forte
      • SiderAL Folico
      • Cardio SiderAL
      • SiderAL Med
      • Cetilar Crema
      • Cetilar Patch
      • Cetilar Tape
      • ApportAL
      • UltraMag
      • Gestalys DHA
      • Novomega
      • Bonecal
      • DiKappa2
    • Junia Pharma
    • Alesco
  • Investor
    • INVESTOR RELATIONS
      • Stock performance
      • Share capital and Shareholders
      • Shares study and research
      • Broker
      • Financial statements
      • Presentations
      • Corporate events
      • Company presentation
      • Notice of meetings
      • SDIR
      • AIM admission document
      • MTA prospectus
    • PRESS
      • Press releases
      • Press review
  • Governance
    • Code of Ethics
    • 231 Model
    • Board of Directors and Committees
    • Company documents
    • Internal dealing
    • Shareholders’ meeting
    • Statutory auditors and Audit firm
    • Sharholders Agreements
  • News
    • Science
    • Corporate
    • Events
    • Social commitment
  • Careers
    • Work with us
    • Job offers
    • Job application
  • Group
    • Companies
    • History
    • Business model
    • Mission and vision
    • Corporate values
    • Commitment to sport
  • Research
    • Pharmaceutical Research
    • Sucrosomial Technology
    • Cetylated Fatty Acids
    • Quality and certifications
  • Brands
    • PharmaNutra
      • SiderAL
      • SiderAL Forte
      • SiderAL Folico
      • Cardio SiderAL
      • SiderAL Med
      • Cetilar Crema
      • Cetilar Patch
      • Cetilar Tape
      • ApportAL
      • UltraMag
      • Gestalys DHA
      • Novomega
      • Bonecal
      • DiKappa2
    • Junia Pharma
    • Alesco
  • Investor
    • INVESTOR RELATIONS
      • Stock performance
      • Share capital and Shareholders
      • Shares study and research
      • Broker
      • Financial statements
      • Presentations
      • Corporate events
      • Company presentation
      • Notice of meetings
      • SDIR
      • AIM admission document
      • MTA prospectus
    • PRESS
      • Press releases
      • Press review
  • Governance
    • Code of Ethics
    • 231 Model
    • Board of Directors and Committees
    • Company documents
    • Internal dealing
    • Shareholders’ meeting
    • Statutory auditors and Audit firm
    • Sharholders Agreements
  • News
    • Science
    • Corporate
    • Events
    • Social commitment
  • Careers
    • Work with us
    • Job offers
    • Job application
  • it
  • en

16 June 2022

Integratori alimentari: quali disturbi possono provocare?

Sorry, this entry is only available in Italian.Il mondo dell’integrazione alimentare, conosciuto anche con il termine nutraceutica, è cresciuto esponenzialmente […]

11 May 2022

Frequent headaches: what if it’s simply magnesium deficiency?

All of us have suffered from headaches at least once in our lifetime, and the symptoms can vary in type, […]

20 April 2022

Iron deficiency, an increasingly female disorder?

Frequent headaches, fatigue and a pale or dull complexion are the typical signs of iron deficiency, a particularly common disorder […]

09 March 2022

Magnesium and PMT: an effective remedy or just a myth?

Magnesium deficiency can play a significant role in a number of different clinical conditions regarding women’s health, and above all […]

10 March 2021

Science, medicine and sport: the health of professional athletes (webinar)

Sorry, this entry is only available in Italian. Il via la prossima settimana a “PharmaNutra Sport Attitude”, una serie di […]

14 October 2019

Scienza e Sport: PharmaNutra e Parma Calcio 1913 portano in Italia le eccellenze del settore medico-sportivo

Sorry, this entry is only available in Italian. Il convegno scientifico internazionale dedicato alle lesioni tendinee in ambito sportivo, tenutosi […]

30 April 2019

PharmaNutra on the front line for sports medicine

During the conference “Medicine Medicine meets the universe of sports”, PharmaNutra presented its two leading brands, SiderAL® and Cetilar®, as […]

07 February 2019

Approfondimenti: le funzioni del magnesio e la sua l’importanza per la salute dell’organismo

Sorry, this entry is only available in Italian.Le funzioni del magnesio sono molteplici, tuttavia la sua importanza per la nostra salute […]

PharmaNutra Spa

Registered office

Via Delle Lenze, 216/b - 56122 Pisa

Phone +39 050 7846500

Fax +39 050 7846524

Electronic billing code

SUBM70N

C.F. / P.Iva / Reg. Impr. 01679440501

Share capital € 1.123.097,70

I.V. | REA 146259

Contacts

Info
info@pharmanutra.it
Commerciale
commerciale@pharmanutra.it
Investor relations
investorrelation@pharmanutra.it
Distribution
internationaldept@pharmanutra.it

Product sites

sideral.it

cetilar.it

ultramag.it

apportal.it

NEWSLETTER

Subscribe to the Pharmanutra newsletter and you will be constantly updated on all our activities.
Read Newsletter Disclosure

Subscribe to the newsletter
Privacy policy Cookie policy General conditions PRIVACY INFORMATION FOR CUSTOMERS

© 2022 2020 PharmaNutra SpA - All rights reserved